Considering that the NF-κB pathway plays an essential role in both intrinsic and acquired resistance against endocrine therapy in patients with BC [26], the strategy of inducing necroptosis in patients insensitive to endocrine therapy should be examined. The gene discussed is NFKB1; the disease is breast cancer.